- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.01. | Nexalin Technology, Inc.: Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025 | 94 | GlobeNewswire (Europe) | DIFS Technology: A Potential Game-Changer for Mental Health Treatments Setting New Benchmarks: 65% Response Rate Shown in Completed Depression Trials Alzheimer's Research Shows Promising Results with... ► Artikel lesen | |
| 10.01. | Nexalin Technology, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 23.12.24 | Nexalin Technology, Inc.: Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic | 113 | GlobeNewswire (Europe) | HOUSTON, TX, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin") the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain... ► Artikel lesen | |
| NEXALIN TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 20.12.24 | Nexalin Technology, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 26.11.24 | Nexalin Technology, Inc.: New Peer-Reviewed Publication Validates Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market | 1 | GlobeNewswire (USA) | ||
| 08.11.24 | Nexalin Technology, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 07.11.24 | (NXL) - Analyzing Nexalin Technology's Short Interest | 4 | Benzinga.com | ||
| 01.11.24 | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.11.24 | Nexalin Technology, Inc.: Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5th | 1 | GlobeNewswire (USA) | ||
| 01.11.24 | Nexalin erfüllt wieder Nasdaq-Anforderungen für Mindestangebotspreisregel | - | Investing.com Deutsch | ||
| 01.11.24 | Nexalin regains Nasdaq compliance with bid price rule | 1 | Investing.com | ||
| 01.11.24 | Nexalin Technology, Inc.: Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements | 80 | GlobeNewswire (Europe) | HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Market ("Nasdaq")... ► Artikel lesen | |
| 01.11.24 | LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 387 | ACCESS Newswire | ORLANDO, FL / ACCESSWIRE / November 1, 2024 / RedChip Companies will air interviews with LOBO EV Technologies Ltd. (Nasdaq:LOBO) and Nexalin Technology, Inc. (Nasdaq:NXL) on the RedChip Small Stocks... ► Artikel lesen | |
| 28.10.24 | Nexalin Technology, Inc.: Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease | 118 | GlobeNewswire (Europe) | HOUSTON, TX, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin") today announced publication of a landmark study titled, "Altered Neuronal... ► Artikel lesen | |
| 28.10.24 | EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients | 3 | Benzinga.com | ||
| 25.10.24 | Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 218 | ACCESS Newswire | ORLANDO, FL / ACCESSWIRE / October 25, 2024 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and Calidi Biotherapeutics, Inc. (NYSE American:CLDI) on the RedChip Small... ► Artikel lesen | |
| 22.10.24 | Nexalin Technology, Inc.: Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA | 112 | GlobeNewswire (Europe) | Gen-3 Halo Headset Designed to Offer Convenient At-Home Treatment Through Virtual Clinic Model Study to Build on Positive Results from Previous Clinical Trial Treating Veterans with Mild Traumatic... ► Artikel lesen | |
| 17.10.24 | Nexalin Technology, Inc.: New Study Shows Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer's Patients | 2 | GlobeNewswire (USA) | ||
| 17.10.24 | EXCLUSIVE: Nano-Cap Nexalin's Drug-Free Alternative For Alzheimer's Shows Improved Memory, Cognitive Function In Small Study | 3 | Benzinga.com | ||
| 14.10.24 | Nexalin Technology, Inc.: Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs | 1 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 53,96 | +0,33 % | Siemens Healthineers-Aktie: Kurs klettert leicht (53,42 €) | Am deutschen Aktienmarkt liegt das Wertpapier von Siemens Healthineers aktuell im Plus. Die Aktie kostete zuletzt 53,42 Euro. Die Aktie von Siemens Healthineers verzeichnet gegenwärtig einen Wertanstieg... ► Artikel lesen | |
| FRESENIUS | 35,910 | -0,83 % | Fresenius SE Aktie: Zeichen stehen auf Gewinn | Die Fresenius SE-Aktie zeigt sich am Handelstag in robuster Verfassung und verzeichnet eine positive Entwicklung im XETRA-Handel. Das Wertpapier konnte im Tagesverlauf um 0,6 Prozent zulegen und erreichte... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 44,460 | +0,27 % | Fresenius Medical Care Aktie: Richtung stimmt! | Die Fresenius Medical Care-Aktie setzt ihren positiven Trend fort und verzeichnet am 19. Januar 2025 einen Kursanstieg von 0,04 Prozent auf 44,88 EUR. Die Entwicklung der vergangenen Wochen zeigt eine... ► Artikel lesen | |
| GERRESHEIMER | 65,70 | -2,01 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 49,500 | +1,43 % | DEUTSCHE BANK RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Carl Zeiss Meditec von 66 auf 55 Euro gesenkt, aber die Einstufung auf "Hold" belassen. Analyst Falko Friedrichs rechnet laut... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 68,42 | 0,00 % | PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 2.8% - Should You Sell? | ||
| BRIGHTSPRING HEALTH SERVICES | 21,210 | +1,53 % | BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living | Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic... ► Artikel lesen | |
| UNITEDHEALTH | 498,15 | -1,08 % | Soll ich diese Aktien jetzt kaufen? Intel, Intuitive Surgical und UnitedHealth im Check | Soll ich diese Aktien jetzt kaufen? Intel, Intuitive Surgical und UnitedHealth im Chec ► Artikel lesen | |
| NANO-X IMAGING | 8,980 | +7,35 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| INTUITIVE SURGICAL | 585,70 | +1,05 % | Intuitive Surgical Q4 2024 Earnings Preview | ||
| PRIVIA HEALTH GROUP | 22,680 | -0,18 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2024 Financial Results | Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared... ► Artikel lesen | |
| ECKERT & ZIEGLER | 48,520 | +0,50 % | Eckert & Ziegler: Positive News reißen nicht ab | Auch im neuen Kalenderjahr läuft eine gute Nachricht nach der nächsten von Eckert & Ziegler über den Ticker. Die Berliner punkteten in dieser Handelswoche gleich doppelt bei den Anlegern. Zum einen... ► Artikel lesen | |
| GENEDX | 75,69 | +1,83 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
| ATRICURE | 39,490 | -0,35 % | Deep Dive Into AtriCure Stock: Analyst Perspectives (9 Ratings) | ||
| PROGYNY | 21,155 | -1,47 % | Witness A Substantial Acquisition As DEBRA MORRIS Acquires Progyny Stock Options Worth $37K |
NEXALIN TECHNOLOGY INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,190 (-6,71 %) liegt der Kurs bei 2,640 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXALIN TECHNOLOGY INC finden Sie auf Wallstreet Online.
